Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemuron Dose-Ranging in Pediatric Anesthesia
NCT00124722Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2004
- Primary completion
- Jul 2007
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, single-blind trial of rocuronium in general anesthesia (3 arms), sponsored by Merck & Co. Primary endpoint: Time to reappearance of T3 (third twitch of TOF). Started Dec 2004; status: completed.
02
Drugs
rocuronium
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT00124722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00124722.